跳至主要内容
临床试验/NCT05485467
NCT05485467已完成不适用

The Role of CD34 + Stem Cells and Biological Markers of Angiogenesis in the Development of Coronary Allograft Vasculopathy in Patients After Heart Transplantation

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
1
主要终点
CD34+ peripheral cell count in heart transplant recipients with and without coronary allograft vasculopathy

研究概览

简要总结

Coronary allograft vasculopathy represents one of the major limiting factors of long-term survival in heart transplant recipients. While extensively researched, the underlying mechanisms of coronary allograft vasculopathy (CAV) after heart transplantation remain incompletely understood. As CD34+ cells represent one of the key determinants of coronary vascular homeostasis we investigated the potential association between CAV and CD34+ cell count in heart transplant recipients.

详细描述

In a single-center prospective pilot cohort study, we aim to enroll 55 adult heart transplant recipients. All patients will undergo coronary CT angiography and the presence of CAV will be defined in accordance with the ISHLT criteria. At the time of CT angiography, patient will undergo detailed clinical evaluation, cardiac echo and we will also collect blood samples, perform extensive biochemical analysis and measure CD34+ cell count in peripheral venous blood using Beckman-Coulter Navios EX flow cytometry with standard antibodies according to ISAGE protocol. Biomarkers of angiogenesis will be evaluated using Luminex assay kit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • heart transplant recipient
  • age > 18 years
  • signed informed consent

排除标准

  • multiorgan transplantation
  • eGFR < 30 ml/min
  • known hypersensitivity to the contrast media
  • history of any malignancy treated with radiation or chemotherapy
  • therapy with mTOR inhibitors
  • rejection > 1R within 90 days before enrollment
  • G-CSF therapy within 30 days of enrollment

结局指标

主要结局

CD34+ peripheral cell count in heart transplant recipients with and without coronary allograft vasculopathy

时间窗: at the time of enrollment

CD34+ peripheral cell count in heart transplant recipients with and without coronary allograft vasculopathy

次要结局

  • The serum levels of biomarkers of angiogenesis in heart transplant recipients with and without coronary allograft vasculopathy(at the time of enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gregor Poglajen

MD, PhD

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验